9780844738826 - competitive strategies in the pharmaceutical industry von american enterprise institute for public policy research (3 Ergebnisse)
Sprache: Englisch
Verlag: American Enterprise Institute for Public Policy Research, 1996
- Hardcover
Anbieter: Better World Books, Mishawaka, IN, USABetter World Books
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Gebraucht - Befriedigend
EUR 11,42
Versand gratisVersand innerhalb von USAAnzahl: 1 verfügbar
Zustand: Good. Pages intact with minimal writing/highlighting. The binding may be loose and creased. Dust jackets/supplements are not included. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.
- Hardcover
Anbieter: WeBuyBooks, Rossendale, LANCS, Vereinigtes KönigreichWeBuyBooks
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Gebraucht - Befriedigend
EUR 52,68
EUR 10,18 VersandVersand von Vereinigtes Königreich nach USAAnzahl: 1 verfügbar
hardcover. Zustand: Good. Most items will be dispatched the same or the next working day. A copy that has been read but remains in clean condition. All of the pages are intact and the cover is intact and the spine may show signs of wear. The book may have minor markings which are not specifically mentioned.
- Hardcover
Anbieter: CSG Onlinebuch GMBH, Darmstadt, DeutschlandCSG Onlinebuch GMBH
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Gebraucht - Gut
EUR 14,36
EUR 95,00 VersandVersand von Deutschland nach USAAnzahl: 1 verfügbar
Gebundene Ausgabe. Zustand: Gut. Gebraucht - Gut ausgesondertes Bibliotheksexemplar mit den üblichen Signaturen, -The growth of government programs and managed care has altered how pharmaceuticals are marketed and sold in the United States. Such change has shortened the expected revenue stream from most products - even though ne…w technologies have increased both the cost and the medical attractiveness of those products. Managers of government and private health care programs are looking for new ways to reduce the cost of drug benefits, while company R&D managers are seeking ways to speed the regulatory process and develop new markets to cover the increasing cost of research. This volume examines various aspects of the continuing policy dispute and offers several views on the future of the pharmaceutical industry.
